<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cancer vaccine</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cancer vaccine'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cancer+vaccine%22&t=%22cancer+vaccine%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:10:43 +0100</lastBuildDate>
        <item>
            <title>Baruch S. Blumberg, MD, 1925-2011</title>
            <link>http://www.medworm.com/index.php?rid=4704204&amp;cid=t_125643_139_f&amp;fid=38879&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FVirologyBlog%2F%7E3%2FdkkxXRq9GWM%2F</link>
            <description>Glenn Rall, a virologist at Fox Chase Cancer Center, sent me the following note:
Baruch S. Blumberg, Nobel Laureate in 1976 for discovery of Hepatitis B (and the eventual development of the vaccine, which probably has saved hundreds of thousands of lives since its introduction), died this past Tuesday (4/5/11).  Barry did most of his work at Fox Chase, though he was an inspiration to many of us, and a catalyst for some tremendously exciting scientific conversations. He was active in science all through his life; in fact, just a few weeks ago, he gave a seminar at the Center, and on the morning of the day of his death, he gave a plenary lecture at a NASA meeting in California.  His HBV work was among the first truly translational studies, and his accomplishments are even more notable give...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4704204</comments>
            <pubDate>Mon, 11 Apr 2011 14:02:29 +0100</pubDate>
            <guid isPermaLink="false">4704204</guid>        </item>
        <item>
            <title>Dr. Vincent Tuohy Reports Breast Cancer Vaccine Works In Mice</title>
            <link>http://www.medworm.com/index.php?rid=3629566&amp;cid=t_125643_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F06%2Fdr-vincent-tuohy-reports-breast-cancer-vaccine-works-mice%2F</link>
            <description>Dr. Vincent Tuohy and other researchers at the Cleveland Clinic report that a breast cancer vaccine has worked in mice. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3629566</comments>
            <pubDate>Thu, 03 Jun 2010 23:24:02 +0100</pubDate>
            <guid isPermaLink="false">3629566</guid>        </item>
        <item>
            <title>Prostate Cancer Vaccine Approved By FDA</title>
            <link>http://www.medworm.com/index.php?rid=3526696&amp;cid=t_125643_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F05%2Fprostate-cancer-vaccine-approved-fda%2F</link>
            <description>The United States Food and Drug Administration has approved the drug Provenge for use against prostate cancer. Oncologists such as Dr. Nina Bhardwaj are heralding it as a major advance. The drug is manufactured by Dendreon Corporation. (Source: Inside Surgery)</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3526696</comments>
            <pubDate>Mon, 03 May 2010 13:34:43 +0100</pubDate>
            <guid isPermaLink="false">3526696</guid>        </item>
        <item>
            <title>TWiV 68: Ode to a plaque</title>
            <link>http://www.medworm.com/index.php?rid=3227365&amp;cid=t_125643_139_f&amp;fid=38879&amp;url=http%3A%2F%2Fwww.sciencemag.org%2Fcontent%2Fvol0%2Fissue2010%2Fimages%2Fdata%2Fscience.1183173%2FDC1%2F1183173s4.mov</link>
            <description>Hosts: Vincent Racaniello, Alan Dove, and Rich Condit
Vincent, Alan, and Rich are enthralled by movies of vaccinia virus plaque formation, then consider how repulsion of superinfection virions leads to rapid virus spread, and a therapeutic prostate cancer vaccine.
This episode is sponsored by Data Robotics Inc. Use the promotion code VINCENT to receive $50 off a Drobo or $100 off a Drobo S.
Win a free Drobo S! Contest rules here.
Download TWiV #68 (58 MB .mp3, 80 minutes)
Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by the RSS feed, or by email.
Links for this episode:

Rapid virus spread by repulsion of superinfection virions
Movie of vaccinia virus plaque formation (.mov)
Movie of GFP-vaccinia virus plaque formation (.mov)
More amazing vaccinia virus movies
Prostate canc...</description>
            <author>virology blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3227365</comments>
            <pubDate>Mon, 01 Feb 2010 13:21:11 +0100</pubDate>
            <guid isPermaLink="false">3227365</guid>        </item>
        <item>
            <title>Cervical cancer vaccine for all Malaysian girls</title>
            <link>http://www.medworm.com/index.php?rid=2838894&amp;cid=t_125643_87_f&amp;fid=34935&amp;url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D7917</link>
            <description>The Government recently announced that it would implement Cervical cancer vaccinations for all girls next year:
The Health Ministry will provide annual human papillomavirus (HPV) vaccination against cervical cancer or cancer of the cervix to an estimated 300,000 13-year-old girls in Malaysia beginning next year.
It is up to the girls to take advantage of the vaccine.
Health Minister Datuk Seri Liow Tiong Lai said RM150mil would be spent annually to make the vaccine available to the girls.
It seems this strategy would be the most cost effective way to combat cervical cancer

 “It costs the government RM382mil annually to treat cervical cancer but vaccination against it costs only RM150mil,” he said after the launch of the Crisis Relief Squad of MCA mobile clinic and Health Awareness Cam...</description>
            <author>Malaysian Medical Resources</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2838894</comments>
            <pubDate>Sat, 26 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2838894</guid>        </item>
        <item>
            <title>Tobacco Plant-Derived Cancer Vaccine, In the works.</title>
            <link>http://www.medworm.com/index.php?rid=1649361&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F344365061%2F</link>
            <description>This report has been causing a stir earlier this week. The good in the evil tobacco? So reports are saying. Okay before we all get too excited&amp;#8230;the tobacco plants used are genetically engineered.
To make the vaccine, researchers took a sample of a patient&amp;#8217;s tumors, which in this trial were made up of B cells (white blood cells that help the body battle disease and infection). They then extracted the gene from the cells that coded for the antigen they needed (to help the immune system recognize the tumors as threats). The key, researchers say, was to make enough of the protein quickly to prompt an immune response.
In this case, the scientists achieved this by inserting the gene into a plant microbe known a tobacco mosaic virus (TMV). Plants are infected with TMV simply by scratch...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1649361</comments>
            <pubDate>Thu, 24 Jul 2008 08:00:06 +0100</pubDate>
            <guid isPermaLink="false">1649361</guid>        </item>
        <item>
            <title>Where has my June gone?</title>
            <link>http://www.medworm.com/index.php?rid=1556545&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F323340828%2F</link>
            <description>Shocks it&amp;#8217;s July and I am working out of the house. I barely made it through June&amp;#8230;maybe it is time to get a new computer set? We&amp;#8217;ll see&amp;#8230;
Anyways, here are a few stuff on cancer I might have missed in the recent days:
&amp;#8216;Designer baby&amp;#8217; to be free from breast cancer?
Men&amp;#8217;s cancer vaccine
Accidental fungus leads to promising cancer drug
That&amp;#8217;s all for now folks..I gotta run!
Tags: 'designer baby', accidental cancer drug, breast-cancer, cancer-drug, cancer-vaccine, free of hereditary breast cancer, fungus, Gardasil, men cancer vaccine, MerckShare This (Source: Cancer Commentary)</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1556545</comments>
            <pubDate>Mon, 30 Jun 2008 16:00:43 +0100</pubDate>
            <guid isPermaLink="false">1556545</guid>        </item>
        <item>
            <title>GSK Won UK Cervical Cancer Contract</title>
            <link>http://www.medworm.com/index.php?rid=1535948&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F316685691%2F</link>
            <description>GlaxoSmithKline has won a contract with the UK&amp;#8217;s NHS to supply its cervical cancer vaccine,
 Cervarix.
The battle to supply a vaccine against cervical cancer for use across Britain has been won by GlaxoSmithKline (GSK).
Cervarix, the GSK vaccine, will be given to girls aged between 12 and 13, starting in September this year, and should prevent about 70 per cent of cervical cancers — saving 400 lives a year when the effect is fully felt.
Read more from The UK Times Online.
Let&amp;#8217;s wait and see what Merck (maker of the other cervical cancer vaccine Gardasil) has to say about this.
Tags: CErvarix, cervical-cancer, cervical-cancer-vaccine, Gardasil, GlaxoSmithKline, Merck, UK NHSShare This (Source: Cancer Commentary)</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1535948</comments>
            <pubDate>Sat, 21 Jun 2008 04:48:23 +0100</pubDate>
            <guid isPermaLink="false">1535948</guid>        </item>
        <item>
            <title>Cancer Commentary Links 3-March-2008</title>
            <link>http://www.medworm.com/index.php?rid=1275002&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F244900625%2F</link>
            <description>Amidst last week&amp;#8217;s frenzy, I might have overlooked some important stuff involving cancer.
The following are still in my week-old (!!) notes:
Smokers Might Benefit From Earlier Colon Cancer Screening
New evidence suggests screening for colorectal cancer, which is now recommended to begin at age 50 for most people, should start five to 10 years earlier for individuals with a significant lifetime exposure to tobacco smoke, a University of Rochester Medical Center study said.
An examination of 3,450 cases found that current smokers were diagnosed with colon cancer approximately seven years earlier than people who never smoked. The study is also one of the first to link exposure to second-hand smoke, especially early in life, with a younger age for colon cancer onset.
 What&amp;#8217;s Good F...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1275002</comments>
            <pubDate>Mon, 03 Mar 2008 15:24:31 +0100</pubDate>
            <guid isPermaLink="false">1275002</guid>        </item>
        <item>
            <title>Cervical Cancer Vaccine Trial Project Starts (?) in Uganda</title>
            <link>http://www.medworm.com/index.php?rid=1212340&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F230245772%2F</link>
            <description>Uganda is one among a few developing countries lined up to benefit from the first cervical cancer vaccine trial project to be implemented by the Programme for Appropriate Technology in Health (PATH).
PATH is a non governmental organisation hoping to come up with a cervical cancer vaccine by year 2010.
Young women in India, Peru, Uganda, and Vietnam will become the first in the developing world to live without fear of cervical cancer-as PATH and our partners begin pilot introduction of new vaccines for the disease,&amp;#8221; reads a statement on the organisation&amp;#8217;s website.
In 2005, cancer killed approximately 14,000 people in Uganda. 8,000 of those were under the age of 70.
Of the various cancers, cervical cancer remains the most common cancer killing women in Uganda according to the Wor...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1212340</comments>
            <pubDate>Wed, 06 Feb 2008 11:50:18 +0100</pubDate>
            <guid isPermaLink="false">1212340</guid>        </item>
        <item>
            <title>Ovarian Cancer Vaccine &quot;Encouraging&quot;</title>
            <link>http://www.medworm.com/index.php?rid=952151&amp;cid=t_125643_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F170180354%2Fovarian_cancer_vaccine_encouraging.html</link>
            <description>An ovarian cancer vaccine, designed to enhance the body&amp;#39;s immune to cancer has shown &amp;quot;encouraging&amp;quot; results said scientists from the Roswell Park Cancer Insitute of Buffalo, New York.While most patients with advanced ovarian cancer respond to chemotherapy, more than 70% die from a reoccurrence of the cancer within five years of diagnosis. The vaccine, an ovarian cancer protien fragment coupled with a molecule to induce immune response, may improve the outcome for that 70%. It induced the immune system to produce antibodies and mobilize specialized T cells which were able to target cancer cells. Researchers detected the vaccine-induced immune cells in patients for up to 12 months after immunization.Lead researcher Professor Kunle Odunsi said: &amp;quot;There is now compelling evide...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=952151</comments>
            <pubDate>Mon, 15 Oct 2007 15:00:56 +0100</pubDate>
            <guid isPermaLink="false">952151</guid>        </item>
        <item>
            <title>Cervical Cancer Vaccine To Undergo Evaluation</title>
            <link>http://www.medworm.com/index.php?rid=901030&amp;cid=t_125643_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F161036890%2F</link>
            <description>Speaking of cervical cancer vaccines, there are two notables: Gardasil by Merck which was approved by the FDA earlier this year and Cervarix by GlaxoSmithKline which is expected to be approved by the FDA later this year (but already approved in Australia).

Regarding these HPV vaccines that will protect women against cervical cancer, the CDC recommends that the vaccine should be routinely given to girls at 11-12 years of age – the stage before young girls are more likely to become sexually active.
Now there is a new project that will evaluate and monitor the effectiveness of these vaccines.
The said project -funded by the national Centers for Disease Control and Prevention (CDC) - will be jointly conducted by the University of Rochester Medical Center (URMC) and the New York State Depart...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=901030</comments>
            <pubDate>Tue, 25 Sep 2007 11:58:23 +0100</pubDate>
            <guid isPermaLink="false">901030</guid>        </item>
        <item>
            <title>Mandatory cervical cancer vaccine surfaces in India</title>
            <link>http://www.medworm.com/index.php?rid=682727&amp;cid=t_125643_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F20%2Fmandatory-cervical-cancer-vaccine-surfaces-in-india%2F</link>
            <description>Filed under: Cervical CancerWith the recent doing and undoing of a mandatory cervical cancer vaccine for teenage girls in Texas, the same looks to be happening in the country of India.Girls between the ages of 11 and 14 would be vaccinated against the virus that causes cervical cancer (HPV) if the new Indian program is implemented by the government there.Is this just the latest attempt by the western pharmaceutical companies to &quot;mandate&quot; vaccinations for profit purposes of is there really a need for this? With an estimated 70% o cervical cancer being attributed to HPV, is mandatory vaccinations the answer? In the U.S. state of Texas, the term &quot;mandatory&quot; did not sit right with constituents.Read&amp;nbsp;|&amp;nbsp;Permalink&amp;nbsp;|&amp;nbsp;Email this&amp;nbsp;|&amp;nbsp;Linking&amp;nbsp;Blogs&amp;nbsp;|&amp;nbsp;Comments...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=682727</comments>
            <pubDate>Wed, 20 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">682727</guid>        </item>
        <item>
            <title>Cervical Cancer and HPV</title>
            <link>http://www.medworm.com/index.php?rid=471174&amp;cid=t_125643_127_f&amp;fid=34828&amp;url=http%3A%2F%2Fdrclouthier.blogspot.com%2F2007%2F02%2Fcervical-cancer-and-hpv.html</link>
            <description>What is interesting in this article and the related statistics is that nowhere does it mention what portion of the 25 percent of women that have the HPV virus actually developed cervical cancer. There is just this loose supposition that some of these HPV cases &quot;could&quot; develop into cervical cancer. How about some statistics on what percentage actually do before we legislate vaccinating nine year old girls with a powerful pharmaceutical. Remember HPV also causes plantar warts and numerous cases of non cancerous and benign cervical dysplasia. (Source: Dr. Steve Clouthier)</description>
            <author>Dr. Steve Clouthier</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=471174</comments>
            <pubDate>Wed, 28 Feb 2007 01:21:00 +0100</pubDate>
            <guid isPermaLink="false">471174</guid>        </item>
        <item>
            <title>Cervical cancer vaccine follow-up: The good and the good</title>
            <link>http://www.medworm.com/index.php?rid=470433&amp;cid=t_125643_117_f&amp;fid=34775&amp;url=http%3A%2F%2Fblogs.webmd.com%2Fhealthy-children%2F2006%2F07%2Fcervical-cancer-vaccine-follow-up-good.html</link>
            <description>In March, I wrote a blog called &quot;Cervical Cancer Vaccine: The good, the bad and the ugly&quot;. In it I talked about an effective and safe new vaccine (&quot;the good&quot;) to prevent contracting human papilloma virus (HPV), by far the leading cause of cervical cancer.The &quot;ugly&quot; was my concern over mounting attacks on the HPV vaccine by those who inisisted it would encourage teens to have sex - to my mind a dubious and dangerous assertion (e.g., in a recent study of virgins, only 7-10% said &quot;fear of a sexually transmitted disease&quot; was a reason not to have sex).Take a look at the blog and especially the fascinating, provocative debate that followed in the comments.*****************************************Dr. P's fears were unfoundedI'm pleased to report my concerns of an effective opposition to this valu...</description>
            <author>Healthy Children</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=470433</comments>
            <pubDate>Tue, 11 Jul 2006 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">470433</guid>        </item>
    </channel>
</rss>

